CCNY expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.33899616026201E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.03960173802875E-11 |
Normal-vs-Stage2 |
2.06900000465637E-08 |
Normal-vs-Stage3 |
2.638000E-04 |
Normal-vs-Stage4 |
3.243800E-02 |
Stage1-vs-Stage2 |
8.302800E-01 |
Stage1-vs-Stage3 |
7.580800E-01 |
Stage1-vs-Stage4 |
6.765200E-01 |
Stage2-vs-Stage3 |
7.039000E-01 |
Stage2-vs-Stage4 |
6.714000E-01 |
Stage3-vs-Stage4 |
8.742800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.09323661234839E-12 |
Normal-vs-AfricanAmerican |
3.1399000000043E-07 |
Normal-vs-Asian |
1.011820E-01 |
Caucasian-vs-AfricanAmerican |
1.859210E-01 |
Caucasian-vs-Asian |
8.359400E-01 |
AfricanAmerican-vs-Asian |
8.113200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.98250354705488E-14 |
Normal-vs-Female |
1.364230E-03 |
Male-vs-Female |
7.99910000000015E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.02810000002229E-06 |
Normal-vs-Extreme_Weight |
1.90725213400356E-12 |
Normal-vs-Obese |
2.43719999959424E-07 |
Normal-vs-Extreme_Obese |
6.49439999556023E-08 |
Normal_Weight-vs-Extreme_Weight |
3.146800E-01 |
Normal_Weight-vs-Obese |
4.779600E-01 |
Normal_Weight-vs-Extreme_Obese |
3.395000E-01 |
Extreme_Weight-vs-Obese |
3.609700E-02 |
Extreme_Weight-vs-Extreme_Obese |
5.562600E-01 |
Obese-vs-Extreme_Obese |
1.222650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.063850E-01 |
Normal-vs-Age(41-60Yrs) |
3.67010000168477E-09 |
Normal-vs-Age(61-80Yrs) |
1.73761005584083E-12 |
Normal-vs-Age(81-100Yrs) |
4.9598000151363E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.495030E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.236800E-03 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.145640E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.343700E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.617900E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.764000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
3.42315065182675E-12 |
Normal-VS-Type2 PRCC |
4.64517313503165E-13 |
Normal-VS-KIRP CIMP |
9.349200E-01 |
Normal-VS-Unclassified PRCC |
1.167450E-04 |
Type1 PRCC-VS-Type2 PRCC |
2.005600E-01 |
Type1 PRCC-VS-KIRP CIMP |
6.961700E-04 |
Type1 PRCC-VS-Unclassified PRCC |
1.527810E-01 |
Type2 PRCC-VS-KIRP CIMP |
2.357600E-04 |
Type2 PRCC-VS-Unclassified PRCC |
3.267700E-02 |
KIRP CIMP-VS-Unclassified PRCC |
3.993600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.69739794336965E-11 |
Normal-vs-N1 |
7.433100E-04 |
Normal-vs-N2 |
5.795600E-03 |
N0-vs-N1 |
1.728810E-01 |
N0-vs-N2 |
5.399000E-01 |
N1-vs-N2 |
9.270200E-01 |
|
|